ABOUT SAMSUNG BIOLOGICS
Samsung Biologics is a full-service provider offering development and cGMP manufacturing services. We deliver a broad range of services from development and manufacturing to fill and finish, covering both clinical molecules and commercial products. Established in April 2011, Samsung Biologics will transform the global healthcare industry over the next decade through our quality, technology and innovation. Our facilities are custom designed for monoclonal & recombinant production with maximum flexibility. Our one-stop services include cell line generation, process and analytical method development, analytical services (characterization, comparability, IPC, lot release & stability), and clinical and commercial bulk cGMP manufacturing of drug substance and drug product. We also provide quality assurance and quality control services, as well as worldwide regulatory compliance standards & support for our customers. We are centrally located in the heart of Asia, within 20 minutes of Incheon International Airport.
CONTACT INFORMATION
Samsung Biologics
300 Songdo Bio Way, Yeonsu-gu
Incheon, 21987
KOREA, REPUBLIC OF
Phone: +82 32 455 3114
Contact: Jinyong Kim
BROCHURES
- Link Your Antibody To Its Fullest Potential
- Trusted End-To-End CDMO Partner For Your Journey
- Take The Right Step To Advance Your Molecule
- Antibody Drug Conjugates: Link Your Antibody To Its Fullest Potential
- Why Samsung Biologics?
- Samsung Biologics: A CDMO Delivering Innovation And Capacity
- The Power Of One: mRNA Services
- Customized CMC Solutions
- Leveraging Proprietary CDO Platforms
FEATURED ARTICLES
- Reducing ADC Timelines With Integrated Development And Manufacturing Services
- Accelerating The Development And Production Of High-Quality Bispecific Antibodies
- Optimizing Sialic Acid Clone Screening Through A High-Throughput Lectin Assay
- Addressing And Adapting To Evolving mRNA Market Trends
- Choose A Partner That Integrates Market Intelligence For Aseptic Fill/Finish
- Critical Success Factors For Cell Line Development
- Ensuring A Successful Technology Transfer
- Ensuring Stability And Safety In Aseptic Fill/Finish Manufacturing
- Implementing A More Robust Post-Pandemic Supply Chain
- CDMO Expertise Accelerates Biologics Development, Manufacturing
- Dedicated To Digitalization
- Continuous Biomanufacturing: N-1 Tech For Higher Productivity, Quality
- How MSAT Drives Efficient Tech Transfer
- Overcoming Cell Line Development Challenges With Early-Stage Processes
- Why Choosing The Right CDMO Partner Is Essential In Today’s Market
- Fundamentals For Bispecific Antibody-Based Cell Line Development
- Optimizing Drug Development Through Customized CMC Solutions
- Breaking Barriers In Heterodimer Formation: S-KiH Platform Technology